Deloris Wiley Bell, MD | |
7000 W 121st St, Ste 100, Overland Park, KS 66209-2008 | |
(913) 498-2015 | |
(913) 469-0176 |
Full Name | Deloris Wiley Bell |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Location | 7000 W 121st St, Overland Park, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679586697 | NPI | - | NPPES |
401838 | Other | KS | BLUE SHIELD KANSAS |
03143017 | Other | KS | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 04-14180 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Deloris Wiley Bell, MD 7000 W 121st St, Ste 100, Overland Park, KS 66209-2008 Ph: (913) 498-2015 | Deloris Wiley Bell, MD 7000 W 121st St, Ste 100, Overland Park, KS 66209-2008 Ph: (913) 498-2015 |
News Archive
Patients who were hospitalized with acute heart failure and had iron deficiency were less likely to return to the hospital if given intravenous iron replacement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.
Even in areas with moderate-to-high levels of traffic pollution, regular physical activity reduced the risk of first and recurrent heart attack, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
A new poll by the Harvard School of Public Health and The Boston Globe finds 59% of Massachusetts residents who are aware of the state's health reform legislation, which was enacted in 2006, support it. A little more than one in four oppose it (28%), and 13% are not sure. The level of public support for the law has declined somewhat in the last year, from 69% saying they support the law in 2008 to 59% in the current poll.
Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.
› Verified 4 days ago
Dr. Richard Noxon Barr, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: #20 Wycklow, Overland Park, KS 66207 Phone: 913-649-1277 | |
Mr. William N Rosenthal, M.D.F.A.C.S. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10740 Nall Avenue, Suite 220, Overland Park, KS 66211 Phone: 913-663-5900 Fax: 913-663-5902 | |
Dr. Timothy B Cavanaugh, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6200 W 135th St, Suite 300, Overland Park, KS 66223 Phone: 913-897-9200 Fax: 913-897-9233 | |
Austin Andersen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 11121 W 95th St, Professional Eyecare, Overland Park, KS 66214 Phone: 913-492-7728 Fax: 913-492-5217 | |
Jason E Stahl, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 8300 College Blvd., Suite 201, Overland Park, KS 66210 Phone: 913-491-3330 Fax: 913-491-9650 | |
Jemshed A Khan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9650 Nall Ave, Overland Park, KS 66207 Phone: 913-696-1154 Fax: 913-696-0984 | |
Ann C Stechschulte, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 7200 W 129th St, Overland Park, KS 66213 Phone: 913-897-9299 Fax: 913-897-3031 |